|
|
|
Insider
Information: |
Lewis Joel |
Relationship: |
|
City: |
Norcross |
State: |
GA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
897,012 |
|
Indirect Shares
|
2,000 |
|
|
Direct
Value |
$2,762,797 |
|
|
Indirect Value
|
$6,160 |
|
|
Total
Shares |
899,012 |
|
|
Total
Value |
$2,768,957 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
16.4%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Galectin Therapeutics Inc |
GALT |
|
2024-04-24 |
897,012 |
2024-04-24 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GALT |
Galectin Therapeutics Inc |
Director |
|
2017-12-14 |
4 |
A |
$2.39 |
$55,001 |
D/D |
23,013 |
50,880 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2018-06-25 |
4 |
B |
$7.06 |
$7,058 |
D/D |
1,000 |
51,480 |
2.39 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2019-01-16 |
4 |
A |
$4.72 |
$55,002 |
D/D |
11,653 |
63,133 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2019-01-29 |
4 |
B |
$4.81 |
$4,805 |
D/D |
1,000 |
64,133 |
2.31 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2019-02-07 |
4 |
B |
$4.48 |
$4,484 |
D/D |
1,000 |
65,133 |
2.31 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2019-04-05 |
4 |
B |
$4.82 |
$3,214 |
D/D |
667 |
65,800 |
2.31 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2019-05-31 |
4 |
B |
$4.28 |
$54,994 |
D/D |
12,849 |
78,649 |
2.39 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2020-01-09 |
4 |
A |
$2.86 |
$58,501 |
D/D |
20,455 |
99,104 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2020-02-09 |
4 |
OE |
$2.39 |
$19,120 |
D/D |
8,000 |
107,104 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2020-09-15 |
4 |
A |
$2.93 |
$15,151 |
D/D |
5,171 |
112,275 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2020-09-30 |
4 |
A |
$2.67 |
$16,666 |
D/D |
6,242 |
118,517 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2020-10-15 |
4 |
A |
$2.87 |
$16,666 |
D/D |
5,807 |
124,324 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2020-10-30 |
4 |
A |
$2.54 |
$16,667 |
D/D |
6,562 |
130,886 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2020-11-13 |
4 |
A |
$2.75 |
$16,668 |
D/D |
6,061 |
136,947 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2020-11-30 |
4 |
A |
$2.60 |
$16,666 |
D/D |
6,410 |
143,357 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2020-12-15 |
4 |
A |
$2.52 |
$16,667 |
D/D |
6,614 |
149,971 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2020-12-31 |
4 |
A |
$2.24 |
$16,666 |
D/D |
7,440 |
157,411 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-01-15 |
4 |
A |
$2.19 |
$16,666 |
D/D |
7,610 |
165,021 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-01-29 |
4 |
A |
$1.96 |
$16,666 |
D/D |
8,503 |
173,524 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-02-15 |
4 |
A |
$2.49 |
$16,666 |
D/D |
6,693 |
180,217 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-02-26 |
4 |
A |
$2.24 |
$16,666 |
D/D |
7,440 |
187,657 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-03-05 |
4 |
A |
$2.22 |
$60,000 |
D/D |
27,027 |
214,684 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-03-15 |
4 |
A |
$2.50 |
$16,668 |
D/D |
6,667 |
194,324 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-03-31 |
4 |
A |
$2.17 |
$16,666 |
D/D |
7,680 |
202,004 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-04-15 |
4 |
A |
$2.23 |
$16,667 |
D/D |
7,474 |
209,478 |
0 |
- |
|
93 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|